Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001563880-22-000001
Filing Date
2022-04-18
Accepted
2022-04-18 16:57:17
Documents
1
Effectiveness Date
2022-04-18
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15916
  Complete submission text file 0001563880-22-000001.txt   17050
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-442332 | Film No.: 22832669
SIC: 2834 Pharmaceutical Preparations